ASTELLAS PHARMA INC PATENTS FACING OPPOSITIONS
Top patents of ASTELLAS PHARMA INC facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP3725778B1 | 18 Aug, 2021 | Formulations Of Enzalutamide | Sep, 2033 | 11 | |
| EP2345410B1 | 30 Dec, 2020 | Controlled Release Pharmaceutical Composition | Sep, 2029 | 6 | |
| EP2554168B1 | 24 Jan, 2018 | Controlled Release Pharmaceutical Composition | Mar, 2031 | 4 | |
| EP3318259B1 | 11 Jan, 2023 | Stable Pharmaceutical Composition For Oral Administration | Jul, 2036 | 2 | |
| EP2824181B1 | 14 Nov, 2018 | Novel Fgfr3 Fusion Product | Mar, 2033 | 2 |